Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
BioAscent Discovery
BioAscent Discovery
Activities:
Research & Development
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
BioAscent reports increasing demand for compound management
Throughout the last two years the company has invested over £1m in its compound management infrastructure and grown its team by 40%
Finance
BioAscent appoints two Associate Directors
Dr Angelo Pugliese and Dr McArthur will be working as Associate Director of in silico discovery and data analysis, and Associate Director of medicinal chemistry respectively
Manufacturing
BioAscent Discovery names Director of Business Development for North America
Julian Abery joins the company as a consultant to expand the company in the US market
Regulatory
Dr Phil Jones to join BioAscent as new CSO
Research & Development
BioAscent appoints new CEO and plans to expand discovery services
Mental Health
Merz outsources its compound management to BioAscent
BioAscent supplies screening plates on demand to provide flexible and cost-effective management of solid and liquid compounds
Ingredients
BioAscent expands compound management services offering in collaboration with Pierre Fabre
Will become the central hub for storage and logistics of Pierre Fabre's plant natural extracts collection
Subscribe now